login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
IVERIC bio Inc (ISEE) Stock News
NASDAQ:ISEE -
US46583P1021
-
Common Stock
39.95
USD
+0.15 (+0.38%)
Last: 7/10/2023, 8:00:03 PM
39.94
USD
-0.01 (-0.03%)
After Hours:
7/10/2023, 8:00:03 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ISEE Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Benzinga
- Mentions:
MRTX
FHLC
IXJ
HART
...
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
2 years ago - By: Astellas Pharma Inc.
Astellas Completes Acquisition of Iveric Bio
2 years ago - By: Benzinga
- Mentions:
FXH
IYH
RYH
VHT
...
From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
2 years ago - By: IVERIC bio, Inc.
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 years ago - By: Seeking Alpha
Iveric Bio stock ticks higher as it sees sale to Astellas closing July 11
2 years ago - By: Seeking Alpha
Iveric Bio shares fall amid concern about Astellas deal (NASDAQ:ISEE)
2 years ago - By: Seeking Alpha
- Mentions:
AMGN
HZNP
Iveric Bio shares gain after HSR waiting period for Astellas deal expires
2 years ago - By: Kahn Swick & Foti, LLC
IVERIC BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. - ISEE
2 years ago - By: Weiss Law
SHAREHOLDER ALERT: Weiss Law Investigates IVERIC bio, Inc.
2 years ago - By: Seeking Alpha
Iveric Bio gains after holder vote on Astellas takeover set for July 6 (NASDAQ:ISEE)
2 years ago - By: IVERIC bio, Inc.
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 years ago - By: Investor's Business Daily
- Mentions:
HZNP
AMGN
PFE
MRK
...
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
2 years ago - By: The Motley Fool
- Mentions:
ANNX
APLS
Why Shares of Annexon Are Plummeting Thursday
2 years ago - By: IVERIC bio, Inc.
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 years ago - By: Kahn Swick & Foti, LLC
IVERIC BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. - ISEE
2 years ago - By: The Motley Fool
- Mentions:
APLS
TGTX
VKTX
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today
2 years ago - By: Investor's Business Daily
- Mentions:
APLS
Biotech Buying Bonanza: Iveric Bio Snags $5.9 Billion Deal From Astellas Pharma
2 years ago - By: Seeking Alpha
- Mentions:
APLS
Apellis weakness on Iveric Bio takeout is buying opportunity - analyst
2 years ago - By: Seeking Alpha
- Mentions:
APLS
Apelliis weakness on Iveric Bio takeout is buying opportunity - analyst (NASDAQ:APLS)
2 years ago - By: Halper Sadeh LLC
ISEE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Iveric bio, Inc. Is Fair to Shareholders
Please enable JavaScript to continue using this application.